Litifilimab May Improve Skin, Joint Symptoms in Lupus
Summary
Litifilimab, an experimental lupus drug, may improve skin and joint disease in adults with systemic lupus erythematosus, an exploratory analysis of a phase 2 trial suggests.
Description from Medscape.
Who is covering this
-
Litifilimab May Improve Skin, Joint Symptoms in Lupus
Litifilimab, an experimental lupus drug, may improve skin and joint disease in adults with systemic lupus erythematosus, an exploratory analysis of a phase 2 trial suggests.
Comments
Comments need JavaScript.